241 related articles for article (PubMed ID: 23994419)
1. Major bleeding during HeartMate II support.
Bunte MC; Blackstone EH; Thuita L; Fowler J; Joseph L; Ozaki A; Starling RC; Smedira NG; Mountis MM
J Am Coll Cardiol; 2013 Dec; 62(23):2188-96. PubMed ID: 23994419
[TBL] [Abstract][Full Text] [Related]
2. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
[TBL] [Abstract][Full Text] [Related]
3. Pre-operative risk factors of bleeding and stroke during left ventricular assist device support: an analysis of more than 900 HeartMate II outpatients.
Boyle AJ; Jorde UP; Sun B; Park SJ; Milano CA; Frazier OH; Sundareswaran KS; Farrar DJ; Russell SD;
J Am Coll Cardiol; 2014 Mar; 63(9):880-8. PubMed ID: 24316083
[TBL] [Abstract][Full Text] [Related]
4. Increased incidence of gastrointestinal bleeding following implantation of the HeartMate II LVAD.
Stern DR; Kazam J; Edwards P; Maybaum S; Bello RA; D'Alessandro DA; Goldstein DJ
J Card Surg; 2010 May; 25(3):352-6. PubMed ID: 20331479
[TBL] [Abstract][Full Text] [Related]
5. Use of left ventricular assist device (HeartMate II): a Singapore experience.
Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
[TBL] [Abstract][Full Text] [Related]
6. Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support).
Starling RC; Naka Y; Boyle AJ; Gonzalez-Stawinski G; John R; Jorde U; Russell SD; Conte JV; Aaronson KD; McGee EC; Cotts WG; DeNofrio D; Pham DT; Farrar DJ; Pagani FD
J Am Coll Cardiol; 2011 May; 57(19):1890-8. PubMed ID: 21545946
[TBL] [Abstract][Full Text] [Related]
7. Low thromboembolic risk for patients with the Heartmate II left ventricular assist device.
John R; Kamdar F; Liao K; Colvin-Adams M; Miller L; Joyce L; Boyle A
J Thorac Cardiovasc Surg; 2008 Nov; 136(5):1318-23. PubMed ID: 19026822
[TBL] [Abstract][Full Text] [Related]
8. Pre-Operative Right Ventricular Dysfunction Is Associated With Gastrointestinal Bleeding in Patients Supported With Continuous-Flow Left Ventricular Assist Devices.
Sparrow CT; Nassif ME; Raymer DS; Novak E; LaRue SJ; Schilling JD
JACC Heart Fail; 2015 Dec; 3(12):956-64. PubMed ID: 26577618
[TBL] [Abstract][Full Text] [Related]
9. Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation.
Uriel N; Pak SW; Jorde UP; Jude B; Susen S; Vincentelli A; Ennezat PV; Cappleman S; Naka Y; Mancini D
J Am Coll Cardiol; 2010 Oct; 56(15):1207-13. PubMed ID: 20598466
[TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal bleeding and subsequent risk of thromboembolic events during support with a left ventricular assist device.
Stulak JM; Lee D; Haft JW; Romano MA; Cowger JA; Park SJ; Aaronson KD; Pagani FD
J Heart Lung Transplant; 2014 Jan; 33(1):60-4. PubMed ID: 24021944
[TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal bleeding with the HeartMate II left ventricular assist device.
Morgan JA; Paone G; Nemeh HW; Henry SE; Patel R; Vavra J; Williams CT; Lanfear DE; Tita C; Brewer RJ
J Heart Lung Transplant; 2012 Jul; 31(7):715-8. PubMed ID: 22425231
[TBL] [Abstract][Full Text] [Related]
12. Gastrointestinal bleeding in recipients of the HeartWare Ventricular Assist System.
Goldstein DJ; Aaronson KD; Tatooles AJ; Silvestry SC; Jeevanandam V; Gordon R; Hathaway DR; Najarian KB; Slaughter MS;
JACC Heart Fail; 2015 Apr; 3(4):303-13. PubMed ID: 25770405
[TBL] [Abstract][Full Text] [Related]
13. Clinical impact of atrial fibrillation in patients with the HeartMate II left ventricular assist device.
Enriquez AD; Calenda B; Gandhi PU; Nair AP; Anyanwu AC; Pinney SP
J Am Coll Cardiol; 2014 Nov; 64(18):1883-90. PubMed ID: 25444141
[TBL] [Abstract][Full Text] [Related]
14. Incidence and management of gastrointestinal bleeding with continuous flow assist devices.
Aggarwal A; Pant R; Kumar S; Sharma P; Gallagher C; Tatooles AJ; Pappas PS; Bhat G
Ann Thorac Surg; 2012 May; 93(5):1534-40. PubMed ID: 22541185
[TBL] [Abstract][Full Text] [Related]
15. Clinical differences between continuous flow ventricular assist devices: a comparison between HeartMate II and HeartWare HVAD.
Lalonde SD; Alba AC; Rigobon A; Ross HJ; Delgado DH; Billia F; McDonald M; Cusimano RJ; Yau TM; Rao V
J Card Surg; 2013 Sep; 28(5):604-10. PubMed ID: 23844652
[TBL] [Abstract][Full Text] [Related]
16. Adverse events in contemporary continuous-flow left ventricular assist devices: A multi-institutional comparison shows significant differences.
Stulak JM; Davis ME; Haglund N; Dunlay S; Cowger J; Shah P; Pagani FD; Aaronson KD; Maltais S
J Thorac Cardiovasc Surg; 2016 Jan; 151(1):177-89. PubMed ID: 26545967
[TBL] [Abstract][Full Text] [Related]
17. Is anti-platelet therapy needed in continuous flow left ventricular assist device patients? A single-centre experience.
Litzler PY; Smail H; Barbay V; Nafeh-Bizet C; Bouchart F; Baste JM; Abriou C; Bessou JP
Eur J Cardiothorac Surg; 2014 Jan; 45(1):55-9; discussion 59-60. PubMed ID: 23671203
[TBL] [Abstract][Full Text] [Related]
18. A Decade of Experience With Continuous-Flow Left Ventricular Assist Devices.
John R; Holley CT; Eckman P; Roy SS; Cogswell R; Harvey L; Shumway S; Liao K
Semin Thorac Cardiovasc Surg; 2016 Summer; 28(2):363-375. PubMed ID: 28043445
[TBL] [Abstract][Full Text] [Related]
19. Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulation.
Boyle AJ; Russell SD; Teuteberg JJ; Slaughter MS; Moazami N; Pagani FD; Frazier OH; Heatley G; Farrar DJ; John R
J Heart Lung Transplant; 2009 Sep; 28(9):881-7. PubMed ID: 19716039
[TBL] [Abstract][Full Text] [Related]
20. Results of the destination therapy post-food and drug administration approval study with a continuous flow left ventricular assist device: a prospective study using the INTERMACS registry (Interagency Registry for Mechanically Assisted Circulatory Support).
Jorde UP; Kushwaha SS; Tatooles AJ; Naka Y; Bhat G; Long JW; Horstmanshof DA; Kormos RL; Teuteberg JJ; Slaughter MS; Birks EJ; Farrar DJ; Park SJ;
J Am Coll Cardiol; 2014 May; 63(17):1751-7. PubMed ID: 24613333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]